Literature DB >> 8491020

The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.

Y Li1, R A Kloner.   

Abstract

BACKGROUND: Adenosine receptor activation has been proposed to explain the cardioprotective effect of ischemic preconditioning in rabbit hearts. We tested this hypothesis in a rat model by assessing whether administration of an adenosine antagonist could block the protective effect of preconditioning and whether adenosine is able to reduce infarct size in rat hearts when given before sustained coronary occlusion. METHODS AND
RESULTS: We assessed the effects of the adenosine antagonist 8-(p-sulfophenyl)theophylline (SPT) and adenosine on myocardial infarct size and the incidence of ventricular arrhythmias in five groups of rats: control (nonpreconditioned)+vehicle, control+SPT, preconditioned+vehicle, preconditioned+SPT, and control (nonpreconditioned)+adenosine. All rats underwent 90 minutes of coronary artery occlusion followed by 4 hours of reperfusion while preconditioned rats underwent three 3-minute episodes of ischemia, each separated by 5 minutes of reperfusion before sustained occlusion. The area at risk was determined by intravascular injection of blue dye during coronary artery occlusion, and infarct size was determined by incubation of heart slices in triphenyltetrazolium chloride. In the nonpreconditioned control rats receiving vehicle, myocardial infarct size expressed as a percentage of the area at risk averaged 55.2 +/- 4.8%. Pretreatment with SPT and adenosine had no effect on infarct size (52.2 +/- 3.1% and 52.6 +/- 3.8%, respectively) in the nonpreconditioned control animals compared with the control animals that received vehicle. Both the preconditioned+vehicle (16.4 +/- 4.3%) and the preconditioned+SPT (18.3 +/- 5.2%) groups had a significant reduction in infarct size (p < 0.01 versus control+vehicle, control+SPT, and control+adenosine), with no difference in infarct size between the two preconditioned groups. The incidence of ventricular tachycardia was significantly decreased in both the preconditioned+vehicle (10%, p < 0.05) and the preconditioned+SPT (25.0%, p < 0.05) groups when compared with the control+vehicle (100%), control+SPT (100%), and control+adenosine groups (100%). There was, however, no significant difference in the incidence of ventricular tachycardia between the preconditioned+vehicle and the preconditioned+SPT groups.
CONCLUSIONS: Because the adenosine antagonist SPT failed to abolish the cardioprotective effects of preconditioning and intravenous adenosine was unable to protect the hearts, it is unlikely that the mechanism of preconditioning is mediated by adenosine receptors in the rat model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491020     DOI: 10.1161/01.cir.87.5.1642

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

4.  Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart.

Authors:  M Bilińska; M Maczewski; A Beresewicz
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 5.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Organ protective mechanisms common to extremes of physiology: a window through hibernation biology.

Authors:  Quintin J Quinones; Qing Ma; Zhiquan Zhang; Brian M Barnes; Mihai V Podgoreanu
Journal:  Integr Comp Biol       Date:  2014-05-21       Impact factor: 3.326

7.  Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.

Authors:  Smadar Yitzhaki; Vladimir Shneyvays; Kenneth A Jacobson; Asher Shainberg
Journal:  Biochem Pharmacol       Date:  2005-04-15       Impact factor: 5.858

8.  Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage.

Authors:  Jasbir S Juggi; Lamia J Hoteit; Fawzi A Babiker; Shaji Joseph; Abu Salim Mustafa
Journal:  Exp Clin Cardiol       Date:  2011

9.  Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide.

Authors:  V Richard; T Blanc; N Kaeffer; C Tron; C Thuillez
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

10.  Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate.

Authors:  Zhonglin Liu; Harrison H Barrett; Gail D Stevenson; Lars R Furenlid; Koon Yan Pak; James M Woolfenden
Journal:  Nucl Med Commun       Date:  2008-02       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.